Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study

AIMS: Non-vitamin K oral anticoagulants are safe and effective for stroke prevention in patients with atrial fibrillation (AF). Data on the safety and efficacy of edoxaban in routine care are limited in Europe. We report 1-year outcomes in patients with AF treated with edoxaban in routine care. METH...

全面介紹

Na minha lista:
書目詳細資料
發表在:Eur Heart J Cardiovasc Pharmacother
Main Authors: de Groot, Joris R, Weiss, Thomas W, Kelly, Peter, Monteiro, Pedro, Deharo, Jean Claude, de Asmundis, Carlo, López-de-Sá, Esteban, Waltenberger, Johannes, Steffel, Jan, Levy, Pierre, Bakhai, Ameet, Zierhut, Wolfgang, Laeis, Petra, Manu, Marius Constantin, Reimitz, Paul-Egbert, De Caterina, Raffaele, Kirchhof, Paulus
格式: Artigo
語言:Inglês
出版: Oxford University Press 2020
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8117428/
https://ncbi.nlm.nih.gov/pubmed/32790837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjcvp/pvaa079
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍